戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 udies, 30%), autonomic (11 studies, 36.7 %), psychic (8 studies, 26.7%) and vestibular (3 studies, 10
2                                              Psychic and somatic anxiety ratings, but not the presenc
3 ients with anxiety disorders rated higher on psychic and somatic anxiety symptoms than did controls.
4                          Combined ratings of psychic and somatic anxiety were associated in a stepwis
5 fficacious than placebo for the treatment of psychic and somatic symptoms of generalized anxiety diso
6 e was positively correlated with severity of psychic anxiety and total anxiety and with resting state
7 mary efficacy variables were final total and psychic anxiety factor scores on the Hamilton anxiety sc
8 oup had significantly (P<.01) improved HAM-A psychic anxiety symptoms compared with the placebo group
9     The relation between indoxyl sulfate and psychic anxiety was mediated only through the metabolite
10 elings and delusion, work and activities and psychic anxiety) and specific thresholds of change in ea
11                                   Agitation, psychic anxiety, and hypochondriasis were more severe in
12 roduce a visual agnosia which causes severe 'psychic blindness' in the first instance, and a persiste
13 ntred practice', 'disempowerment' and 'intra-psychic coping'.
14                                              Psychic depression correlated positively with metabolism
15 em HDRS for all subjects and ProMax rotated: psychic depression, loss of motivated behavior, psychosi
16 for making sense of psychic difficulties and psychic differences.
17 ther cultural resources, for making sense of psychic difficulties and psychic differences.
18 k were obesity (OR, 95% CI 2.46, 1.11-5.41), psychic disorders (2.87, 0.89-9.30-borderline), nasal po
19 t be implicated in the neurodegenerative and psychic disorders associated with an impairment of the b
20 n coupled with state variables such as acute psychic distress or dopamine receptor antagonism, produc
21 s measured using the Community Assessment of Psychic Experiences (n = 3484; 2161 [62.0%] female).
22        Outcomes were Community Assessment of Psychic Experiences 15-item, Patient Health Questionnair
23 ) negative symptoms (Community Assessment of Psychic Experiences at 16.5 years of age), (3) depressiv
24                  The Community Assessment of Psychic Experiences was completed to assess psychosis-li
25      The Hamilton anxiety scale total score, psychic factor, and somatic factor and the Clinical Glob
26 out the brain-mind, and how both somatic and psychic factors contribute to the development and mainte